These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 27284341

  • 1. MicroRNA-138 suppresses proliferation, invasion and glycolysis in malignant melanoma cells by targeting HIF-1α.
    Chen Y, Cao KE, Wang S, Chen J, He B, He GU, Chen Y, Peng B, Zhou J.
    Exp Ther Med; 2016 Jun; 11(6):2513-2518. PubMed ID: 27284341
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-33b inhibits cell proliferation and glycolysis by targeting hypoxia-inducible factor-1α in malignant melanoma.
    Zhao Y, Wu C, Li L.
    Exp Ther Med; 2017 Aug; 14(2):1299-1306. PubMed ID: 28781622
    [Abstract] [Full Text] [Related]

  • 3. miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α.
    Zhou J, Xu D, Xie H, Tang J, Liu R, Li J, Wang S, Chen X, Su J, Zhou X, Xia K, He Q, Chen J, Xiong W, Cao P, Cao K.
    Cancer Biol Ther; 2015 Aug; 16(6):846-55. PubMed ID: 25891797
    [Abstract] [Full Text] [Related]

  • 4. CircRBM33 downregulation inhibits hypoxia-induced glycolysis and promotes apoptosis of breast cancer cells via a microRNA-542-3p/HIF-1α axis.
    Jiang Y, Zhang M, Yu D, Hou G, Wu J, Li F.
    Cell Death Discov; 2022 Mar 22; 8(1):126. PubMed ID: 35318311
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-124 suppresses proliferation and glycolysis in non-small cell lung cancer cells by targeting AKT-GLUT1/HKII.
    Zhao X, Lu C, Chu W, Zhang B, Zhen Q, Wang R, Zhang Y, Li Z, Lv B, Li H, Liu J.
    Tumour Biol; 2017 May 22; 39(5):1010428317706215. PubMed ID: 28488541
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-18b inhibits the growth of malignant melanoma via inhibition of HIF-1α-mediated glycolysis.
    Chen Y, Zhang Z, Luo C, Chen Z, Zhou J.
    Oncol Rep; 2016 Jul 22; 36(1):471-9. PubMed ID: 27220837
    [Abstract] [Full Text] [Related]

  • 7. circDNMT1 Promotes Malignant Progression of Gastric Cancer Through Targeting miR-576-3p/Hypoxia Inducible Factor-1 Alpha Axis.
    Li H, Cao B, Zhao R, Li T, Xu X, Cui H, Deng H, Gao J, Wei B.
    Front Oncol; 2022 Jul 22; 12():817192. PubMed ID: 35712504
    [Abstract] [Full Text] [Related]

  • 8. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
    He C, Wang L, Zhang J, Xu H.
    Mol Cancer; 2017 Feb 07; 16(1):35. PubMed ID: 28173803
    [Abstract] [Full Text] [Related]

  • 9. miR-532-3p suppresses proliferation and invasion of ovarian cancer cells via GPNMB/HIF-1α/HK2 axis.
    Tuo X, Zhou Y, Yang X, Ma S, Liu D, Zhang X, Hou H, Wang R, Li X, Zhao L.
    Pathol Res Pract; 2022 Sep 07; 237():154032. PubMed ID: 35914373
    [Abstract] [Full Text] [Related]

  • 10. MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer.
    Niu Y, Jin Y, Deng SC, Deng SJ, Zhu S, Liu Y, Li X, He C, Liu ML, Zeng Z, Chen HY, Zhong JX, Ye Z, Wang CY, Zhao G.
    Oncogene; 2018 Mar 07; 37(13):1743-1758. PubMed ID: 29343850
    [Abstract] [Full Text] [Related]

  • 11. LncRNA NEAT1 promotes angiogenesis of retinoblastoma cells through regulation of the miR-106a/HIF-1α axis.
    Liu Y, Xin Z, Zhang K, Jin X, Wang D.
    Heliyon; 2024 Mar 30; 10(6):e27653. PubMed ID: 38524558
    [Abstract] [Full Text] [Related]

  • 12. microRNA-33a-5p increases radiosensitivity by inhibiting glycolysis in melanoma.
    Cao K, Li J, Chen J, Qian L, Wang A, Chen X, Xiong W, Tang J, Tang S, Chen Y, Chen Y, Cheng Y, Zhou J.
    Oncotarget; 2017 Oct 13; 8(48):83660-83672. PubMed ID: 29137372
    [Abstract] [Full Text] [Related]

  • 13. HIF-1α/Malat1/miR-141 Axis Activates Autophagy to Increase Proliferation, Migration, and Invasion in Triple-negative Breast Cancer.
    Xu F, Hu Y, Gao J, Wang J, Xie Y, Sun F, Wang L, Miyamoto A, Xia O, Zhang C.
    Curr Cancer Drug Targets; 2023 Oct 13; 23(5):363-378. PubMed ID: 36579395
    [Abstract] [Full Text] [Related]

  • 14. MiRNA-451 Inhibits Glioma Cell Proliferation and Invasion Through the mTOR/HIF-1α/VEGF Signaling Pathway by Targeting CAB39.
    Nan Y, Guo H, Guo L, Wang L, Ren B, Yu K, Huang Q, Zhong Y.
    Hum Gene Ther Clin Dev; 2018 Sep 13; 29(3):156-166. PubMed ID: 30180756
    [Abstract] [Full Text] [Related]

  • 15. LncRNA MIR17HG promotes the proliferation, migration, and invasion of retinoblastoma cells by up-regulating HIF-1α expression via sponging miR-155-5p.
    Yan J, Deng YX, Cai YL, Cong WD.
    Kaohsiung J Med Sci; 2022 Jun 13; 38(6):554-564. PubMed ID: 35253975
    [Abstract] [Full Text] [Related]

  • 16. Expression and role of microRNA 18b and hypoxia inducible factor-1α in placental tissues of preeclampsia patients.
    Wang S, Wang X, Weng Z, Zhang S, Ning H, Li B.
    Exp Ther Med; 2017 Nov 13; 14(5):4554-4560. PubMed ID: 29104664
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-138 inhibits hypoxia-induced proliferation of endothelial progenitor cells via inhibition of HIF-1α-mediated MAPK and AKT signaling.
    Zhou W, Zhou W, Zeng Q, Xiong J.
    Exp Ther Med; 2017 Mar 13; 13(3):1017-1024. PubMed ID: 28450935
    [Abstract] [Full Text] [Related]

  • 18. CircLARP4 Suppresses Cell Proliferation, Invasion and Glycolysis and Promotes Apoptosis in Non-Small Cell Lung Cancer by Targeting miR-135b.
    Lu H, Guo Q, Mao G, Zhu J, Li F.
    Onco Targets Ther; 2020 Mar 13; 13():3717-3728. PubMed ID: 32440141
    [Abstract] [Full Text] [Related]

  • 19. Cancer-associated fibroblast-secreted miR-421 promotes pancreatic cancer by regulating the SIRT3/H3K9Ac/HIF-1α axis.
    Zhou B, Lei JH, Wang Q, Qu TF, Cha LC, Zhan HX, Liu SL, Hu X, Sun CD, Guo WD, Qiu FB, Cao JY.
    Kaohsiung J Med Sci; 2022 Nov 13; 38(11):1080-1092. PubMed ID: 36200682
    [Abstract] [Full Text] [Related]

  • 20. The inhibitive effect of sh-HIF1A-AS2 on the proliferation, invasion, and pathological damage of breast cancer via targeting miR-548c-3p through regulating HIF-1α/VEGF pathway in vitro and vivo.
    Guo X, Lee S, Cao P.
    Onco Targets Ther; 2019 Nov 13; 12():825-834. PubMed ID: 30774370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.